Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells

Clinical Cancer Research

Volumn 6, Issue 4, 2000, Pages 1563-1573

  Sun, Shi Yong ^a   Yue, Ping ^a,g   Mao, Li ^a   Dawson, Marcia I ^b   Shroot, Braham ^c   Lamph, William W ^d   Heyman, Richard A ^d   Chandraratna, Roshantha A S ^e   Shudo, Koichi ^f   Hong, Waun K ^a   Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b SRI INTERNATIONAL   (United States)

^c Galderma R and D   (France)

^d LIGAND PHARMACEUTICALS INC   (United States)

^e Retinoid Research   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)BENZO[B]THIOPHENE 6 CARBOXYLIC ACID; 3,5 DI TERT BUTYL 4' CHALCONECARBOXYLIC ACID; 4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 4 [1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CYCLOPROPYL]BENZOIC ACID; 4 [1 HYDROXY 3 OXO 3 (5,6,7,8 TETRAHYDRO 3 HYDROXY 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 4 [2 METHYL 1 (5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL) 1 PROPENYL]BENZOIC ACID; 4 [2,3 (2,5 DIMETHYL 2,5 HEXANO) 5 METHYL 5H DIBENZO[B,E][1,4]DIAZEPIN 11 YL]BENZOIC ACID; 4 [3,5 BIS(TRIMETHYLSILYL)BENZAMIDO]BENZOIC ACID; 4 [7 ADAMANTYL 6 [(2 METHOXYETHOXY)METHOXY] 2 NAPHTHYL]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADAPALENE; ANTINEOPLASTIC AGENT; BEXAROTENE; CD 2314; CD 2325; CD 2366; CD 336; CD 666; LE 540; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; SR 11203; SR 11234; SR 11236; SR 11238; SR 11254; SR 11363; SR 11364; SR 3985; TAMIBAROTENE; TD 550; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; GENE EXPRESSION REGULATION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; BLOTTING, NORTHERN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034048911     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer. N. Engl. J. Med., 328: 184-194, 1993.
2. Landis, S. H., Murray, T., Bolden, S., and Wings, P. A. Cancer statistics, 1999. Cancer J. Clin., 49: 8-31, 1999.
3. DeLuca, L. M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J., 5: 2924-2933, 1991.
4. Jetten, A. M., Kim, J. S., Sacks, P. G., Rearick, J. I., Lotan, D., Hong, W. K., and Lotan, R. Suppression of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid. Int. J. Cancer, 45: 195-202, 1990.
5. Sacks, P. G., Oke, V., Amos, B., Vasey, T., and Lotan, R. Modulation of growth, differentiation, and glycoprotein synthesis by β-all-trans retinoic acid in a multicellular tumor spheroid model for squamous carcinoma of the head and neck. Int. J. Cancer, 45: 926-933, 1989.
6. Zou, C-P., Clifford, J. L., Xu, X-C., Sacks, P. G., Chambon, P., Hong, W. K., and Lotan, R. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res., 54: 5479-5487, 1994.
7. Oridate, N., Lotan, D., Xu, X-C., Hong, W. K., and Lotan, R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous carcinma cell lines. Clin. Cancer Res., 2: 855-863, 1996.
8. Hong, W. K., and Itri, L. M. Retinoids and human cancer. In: M. B. Sporn, A. B. Roberts, and D. S. Goodman (eds.), The Retinoids, pp. 597-658. New York: Raven Press, 1994.
9. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 940-954, 1996.
10. Lehmann, J. M., Dawson, M. I., Hobbs, P. D., Husmann, M., and Pfahl, M. Identification of retinoids with nuclear receptor subtype-selective activities. Cancer Res., 51: 4804-4809, 1991.
11. Bernard, B. A., Bernardon, J-M., Delescluse, C., Martin, B., Lenoir, M-C., Margnan, J., Charpentier, B., Pilgrim, W. R., Reichert, U., and Shroot, B. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem. Biophys. Res. Commun., 186: 977-983, 1992.
12. Delescluse, C., Cavey, M. T., Martin, B., Bernard, B. A., Reichert, U., Maignan, J., Darmon, M., and Shroot, B. Selective high affinity retinoic acid receptor α or β-γ ligands. Mol. Pharmacol., 40: 556-562, 1991.
13. Lehmann, J. M., Jong, L., Fanjul, A., Cameron, J. F., Lu, X. P., Haefner, P., Dawson, M. I., and Pfahl, M. Retinoids selective for retinoid X receptor response pathways. Science (Washington DC), 258: 1944-1946, 1992.
14. Chen, J-Y., Penco, S., Ostrowski, J., Balaguer, P., Pons, M., Starrett, J. E., Reczek, P., Chambon, P., and Gronemeyer, H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J., 14: 1187-1197, 1995.
15. Fanjul, A., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X-P., and Pfahl, M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature (Lond.), 372: 107-110, 1994.
16. Dawson, M. I., Jong, L., Hobbs, P. D., Cameron, J. F., Chao, W-R., Pfahl, M., Lee, M-O., Shroot, B., and Pfahl, M. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J. Med. Chem., 38: 3368-3383, 1995.
17. Charpentier, B., Bernardon, J.-M., Eustache, J., Millois, C., Martin, B., Michel, S., and Shroot, B. Synthesis, structure-affinity relationships, and biological activities of ligands bonding to retinoic acid receptor subtypes. J. Med. Chem., 38: 4993-5006, 1995.
18. Kagechika, H., Kawachi, H., Hashimoto, Y., and Shudo, K. Retinobenzoic acids. 2. Structure-activity relationships of chalcone-4-carboxylic acids and flavone-4′-caboxylic acids. J. Med. Chem., 32: 834-840, 1989.
19. Kaneko, S., Kagechika, H., Kawachi, E., Hashimoto, Y., and Shudo, K. Retinoid antagonists. Med. Chem. Res., 1: 220-225, 1991.
20. Umemiya, H., Kawachi, E., Kagechika, H., Fukusawa, H., Hashimoto, Y., and Shudo, K. Synergists for retinoid in cellular differentiation of human promyelocytic leukemia cells HL-60. Chem. Pharm. Bull., 43: 1827-1829, 1995.
21. Boehm, M. F., Zhang, L., Badea, B. A., White, S. K., Mais, D. E., Berger, E., Suto, C. M., Goldman, M. E., and Heyman, R. A. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids. J. Med. Chem., 37: 2930-2941, 1994.
22. Beard, R. L., Chandraratna, R. A., Colon, D. F., Gillett, S. J., Henry, E., Marler, D. K., Song, T., Denys, L., Garst, M. E., Arefneg, T., Klein, E., Gil, D. W., Wheeler, L., Kochhar, D. M., and Davies, J. A. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids. J. Med. Chem., 38: 2820-2829, 1995.
23. Sun, S-Y., Yue, P., Shroot, B., Michel, S., Dawson, M. I., Lamph, W. W., Heyman, R. A., Teng, M. Chandraratna, R. A. S., Shudo, K., Hong, W. K., and Lotan, R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res., 57: 4931-4939, 1997.
24. Krause, C. J., Carey, T. E., Ott, R. W., Hurbis, C., and McClatchey, K. D., and Regezi, J. A. Human squamous cell carcinoma: establishment and characterization of new permanent cell lines. Arch. Otolaryngol., 107: 703-710, 1981.
25. Grenman, R., Carey, T. E., McClatchey, K. D., Wagner, J. G., Pekkola-Heino, K., Schwartz, D. R., Wolf, G. T., Lacivita, L. P., Ho, L., Baker, S. R., Krause, C, J., and Lichter, A. S. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer (Phila.), 67: 2741-2747, 1991.
26. Sacks, P. G., Parnes, S. M., Gallick, G. E., Mansouri, Z., Lichtner, R., Satya-Prakash, K. L., Pathak, S., and Parsons, D. F. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumor of the head and neck. Cancer Res., 48: 2858-2866, 1988.
27. Reiss, M., Pitman, S. W., and Sartorelli, A. C. Modulation of the terminal differentiation of human squamous carcinoma cells in vitro by all-trans retinoic acid. J. Natl. Cancer Inst., 74: 1015-1023, 1985.
28. Rupniak, H. T., Rowlatt, C., Lanc, E. B., Steele, J. G., Trejdosiewicz, L. K., Laskiewicz, B., Porey, S., and Hill B. T. Characteristic of four new human cell lines derived from squamous cell carcinomas of the head and neck. J. Natl. Cancer Inst., 75: 621-635, 1985.
29. Pfahl, M., Tzukerman, M., Zhang, X-K., Lehmann, J. M., Hermann, T., Wills, K. N., and Graupner, G. Nuclear retinoic acid receptors: Cloning, analysis, and function. Methods Enzymol., 189: 256-271, 1990.
30. Petkovitch, M., Brand, N. J., Krust, A., and Chambon, P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature (Lond.), 330: 444-450, 1987.
31. Brand, N., Petkovitch, M., Krust, A., Chambon, P, The, H. D., Marchio, M., Tiollais, P., and Dejean, A. Identification of a second human retinoic acid receptor. Nature (Lond.), 332: 850-853, 1988.
32. Krust, A., Kastner, P., Petkovitch, M., Zelent, A., and Chambon, P. A third human retinoic acid receptor, hRAR-γ. Proc. Natl. Acad. Sci. USA, 86: 5310-5314, 1989.
33. Mangelsdorf, D. J., Borgmeyer, U., Heyman, R., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., and Evans, R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev., 6: 329-344, 1992.
34. Lotan, R., Dawson, M. I., Zou, C. C., Jong, L., Lotan, D., and Zou, C-P. Enhanced efficacy of combinations of retinoic acid-and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.
35. Roy, B., Taneja, R., and Chambon, P. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol., 15: 6481-6487, 1995.
36. 3 signaling. Nature (Lond.), 355: 446-449, 1992.
37. Yu, V. C., Delsert, C., Andersen, B., Holloway, J. M., Devary, O. V., Naar, A. M., Kim S. Y., Boutin, J-M., Glass, C. K., and Rosentfeld, M. G. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response element. Cell, 67: 1251-1266, 1991.
38. Zhang, X. K., Hoffmann, B., Tran, P. B-V., Graupner, G., and Pfahl, M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptor. Nature (Lond.), 355: 441-446, 1992.
39. Zhang, X. K, Lehmann, J., Hoffman, B., Dawson, M. I., Cameron, J., Graupner, G., Hermann, T., Tran, P., and Pfahl, M. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature (Lond.), 358: 587-591, 1992.
40. Dawson, M. I., Elstner, E., Kizaki, M., Chen, D-L., Pakkala, S., Kerner, B., and Koeffler, H. P. Myeloid differentiation mediated through retinoic acid receptor/retinoid X receptor (RXR), not RXR/ RXR pathway. Blood, 84: 446-452, 1994.
41. Sheikh, M. S., Shao, Z. M., Li, X-S., Dawson M. I., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H., and Fontana, J. A. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem., 269: 21440-21447, 1994.
42. Xiao, J-H., Durand, B., Chambon, P., and Voorhees, J. J. Endogenous retinoic acid receptor (RAR)-retinoid X receptor (RXR) heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. J. Biol. Chem., 270: 3001-3011, 1995.
43. Westin, S., Kurokawa, R., Nolte, R. T., Wisely, G. B., McInerney, E. M., Rose, D. W., Milburn, M. V., Rosenfeld, M. G., and Glass, C. K. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature (Lond.), 395: 199-202, 1998.
44. Sun, S-Y., Kurie, J. M., Yue, P., Dawson, M. I., Shroot, B., Chandraratna, R. A. S., Hong, W. K., and Lotan, R. Differential responses of normal, premaligant, and maligant human bronchial epithelial cells to receptor-selective retinoids. Clin. Cancer Res., 5: 431-437, 1999.
45. Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G., and Glass, C. K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (Lond.), 377: 451-454, 1995.
46. Torchia, J., Rose, D. W., Inostroza, J., Kamel, Y., Westin, S., Glass, C. K., and Rosenfeld, M. G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature (Lond.), 387: 677-684, 1997.
47. Onate, S. A., Ysai, S. Y., Tsai, M-J., and O'Malley, B. W. Sequence and characterizationof a coactivator for the steroid hormone receptor superfamily. Science (Washington DC), 270: 1354-1357, 1995.
48. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
49. Pfahl, M. Nuclear receptor/AP-1 interaction. Endocrinol. Rev., 14: 651-658, 1992.
50. Sun, S-Y., Yue, P., Wu, G. S., El-Deiry, W. S., Shroot, B., Hong W. K., and Lotan, R. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene, 18: 2357-2365, 1999.
51. Adachi, H., Preston, G., Harvat, B., Dawson, M. I., and Jetten, A. M. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am. J. Respir. Cell Mol. Biol., 18: 323-333, 1998.
52. Li, Y., Lin, B., Agadir, A., Liu, R., Dawson, M. I., Reed, J. C., Fontana, J. A., Bost, F., Hobbs, P. D., Zheng, Y., Chen, G-Q., Shroot, B., Mercola, D., and Zhang, X-K. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol. Cell. Biol., 18: 4719-4731, 1998.
53. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells: Oncogene, 11: 493-504, 1995.
54. Schadendorf, D., Kern, M. A., Artuc, M., Pahl, H. L., Rosenbach, T., Fichtner, I., Nurnberg, W., Stuting, S., Stebut, E. V., Worm, M., Makki, A., Jurgovsky, K., Kolde, G., and Henz, B. M. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol., 135: 1889-1898, 1996.
55. Hsu, C. A., Rishi, A. K., Li, X-S., Gerald, T. M., Dawson, M. I., Schiffer, C., Reichett, U., Shroot, B., Poirer, G. C., and Fontana, J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood, 89: 4470-4479, 1997.
56. Sun, S-Y., Yue, P., Wu, G. S., El-Deiry, W. S., Shroot, B., Hong W. K., and Lotan, R. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells. Cancer Res., 59: 2829-2833, 1999.
57. Sun, S-Y., Yue, P., Shroot, B., Hong W. K., and Lotan, R. Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung cancer cells. Oncogene, 18: 3894-3901, 1999.
58. Wu, G. S., Burns, T. F., McDonald III, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D-D., Zhou, J-Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and El-Deiry, W. S. Killer/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet., 17: 141-143, 1997.
59. Sheikh, M. S., Burns, T. F., Huang, Y., Wu, G. S., Amundson, S., Brooks, K. S., Fornace, A. J., and El-Deiry, W. S. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α. Cancer Res., 58: 1593-1598, 1998.